UK-wide excellence in paediatrics

15 Jun 2026, 2:42 p.m.

A man wearing a grey jumper and black thick rimmed glasses sits in an audience, holding a portable microphone as he asks a question to a speaker.

Through the Paediatric Excellence Initiative (PEI), the NIHR GOSH Biomedical Research Centre (BRC) is extending its impact beyond a single organisation - building a connected, collaborative system to accelerate paediatric research across the UK.

The future of paediatric research depends not only on individual excellence, but on collaboration at scale. Working across partner sites in Birmingham, Sheffield and Alder Hey, the PEI is creating a shared infrastructure for developing researchers, enabling talent, ideas and best practice to flow across institutions.

Its impact is already significant.

PEI partners have:

  • Leveraged over £1.3 million in external funding
  • Established Junior Faculty networks modelled on that of the NIHR GOSH BRC
  • Contributed to national events and training programmes
  • Collaborated on research projects and capacity-building initiatives

Professor Sir Terrence Stephenson, co-lead of the Career Development Academy said: “We are very proud of what we have achieved through the Paediatric Excellence Initiative (PEI). The funding from the NIHR BRC at GOSH is crucial, but the support and belief from the leadership is truly what drives transformation in this space.

“As a community, we must put aside self-interest or territorialism to drive forward advances in child health, build peer networks and ensure strong leadership for the future. This is what the PEI is achieving.”

Critically, the initiative supports shared learning. Programmes developed at GOSH, such as training models, fellowships and events, are adapted and adopted by partner sites, accelerating progress across the system.

Early career researchers benefit directly from this model, gaining:

  • Access to wider networks and expertise
  • Opportunities to collaborate nationally
  • Greater visibility and support for career progression

Professor Sir Terence Stephenson, co-lead of the Career Development Academy said: “We are very proud of what we have achieved through the Paediatric Excellence Initiative (PEI). The funding from the NIHR BRC at GOSH is crucial, but the support and belief from the leadership is truly what drives transformation in this space.

“As a community, we must put aside self-interest or territorialism to drive forward advances in child health, build peer networks and ensure strong leadership for the future. This is what the PEI is achieving.”

A group of 10-15 people are gathered around a table, attentively watching someone give a presentation at the front of the room

Alder Hey held an inaugural Junior Faculty meeting in November 2025 with over 30 attendees. Local charities, career development and Research and Development staff presented, supported through GOSH Charity funding to the NIHR GOSH BRC.

A group of people stand posed for the camera, smiling broadly.

Junior Faculty representatives from across the Paediatric Excellence Initiative met at GOSH in 2023 to share best practise in developing Early Career Researcher networks for paediatric researchers at their Trusts.

From complex science to clear communication

Across multiple projects at GOSH, patients, families and young people are playing a vital role in transforming how research is communicated

Building the next generation of paediatric research leaders

From early career clinicians to emerging scientists, the NIHR GOSH Biomedical Research Centre (BRC)’s Academic Training Weekend is shaping the future of paediatric research - bringing together talent, expertise and ambition from across the UK.

A catalyst to unlock the next generation of research leaders

The NIHR GOSH Biomedical Research Centre (BRC) Fellowships are transforming early-career researchers into independent leaders - driving innovation, attracting millions in funding and shaping the future of paediatric science.

Gene therapy successfully treats deadly childhood liver disease in mice

Researchers at GOSH and UCL have used a new gene therapy to successfully treat a deadly childhood liver disease in mice.